Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? (Q36832533)

16 August 2017

1 reference

title

Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? (English)

1 reference

16 August 2017

0 references

2

Robert M Silver

1 reference

16 August 2017

Erin A S Clark

1

1 reference

16 August 2017

D Ware Branch

series ordinal

3

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Current Rheumatology Reports

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

219-225

1 reference

Anti-cardiolipin antibodies and pre-eclampsia

16 August 2017

cites work

1 reference

12 December 2020

The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction

1 reference

12 December 2020

Validation of the Sapporo criteria for antiphospholipid syndrome

1 reference

12 December 2020

Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy

1 reference

12 December 2020

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

12 December 2020

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism

1 reference

12 December 2020

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience

1 reference

12 December 2020

Antiphospholipid syndrome: obstetric diagnosis, management, and controversies

1 reference

12 December 2020

The antiphospholipid syndrome

1 reference

12 December 2020

Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation.

1 reference

12 December 2020

Underlying disorders associated with severe early-onset preeclampsia

1 reference

12 December 2020

Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia

1 reference

12 December 2020

Obstetric complications associated with the lupus anticoagulant

1 reference

12 December 2020

Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes

1 reference

12 December 2020

Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome.

1 reference

12 December 2020

A study of 75 pregnancies in patients with antiphospholipid syndrome

1 reference

12 December 2020

A prospective study on the occurrence of autoantibodies in low-risk pregnancies

1 reference

12 December 2020

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

12 December 2020

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

1 reference

12 December 2020

The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation

1 reference

12 December 2020

Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture

1 reference

12 December 2020

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

12 December 2020

Anticardiolipin antibodies in pregnancy induced hypertension

1 reference

12 December 2020

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

1 reference

12 December 2020

A study of sixty pregnancies in patients with the antiphospholipid syndrome.

1 reference

12 December 2020

Anticardiolipin antibodies and the severity of preeclampsia-eclampsia

1 reference

12 December 2020

Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

1 reference

12 December 2020

Antiphospholipid antibodies in women at risk for preeclampsia

1 reference

12 December 2020

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

1 reference

12 December 2020

The association of antiphospholipid antibodies with severe early-onset pre-eclampsia

1 reference

12 December 2020

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

12 December 2020

Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia

1 reference

12 December 2020

Antiphospholipid antibodies and preeclampsia: a case-control study

1 reference

12 December 2020

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations

1 reference

12 December 2020

Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure

1 reference

12 December 2020

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

12 December 2020

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

12 December 2020

The significance of antiphospholipid antibodies in pregnant women with chronic hypertension

1 reference

12 December 2020

Antiphospholipid antibodies in pre‐eclamptic women: Relation to growth retardation and neonatal outcome

1 reference

12 December 2020

Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy

1 reference

12 December 2020

The association of antiphospholipid antibodies with severe preeclampsia

1 reference

12 December 2020

Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation

1 reference

12 December 2020

Autoimmune disease in pregnancy. Systemic lupus erythematosus and antiphospholipid syndrome.

1 reference

12 December 2020

Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays.

1 reference

12 December 2020

Antiphospholipid antibodies in patients with preeclampsia

1 reference

12 December 2020

Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls

1 reference

12 December 2020

beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women

1 reference

12 December 2020

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

1 reference

12 December 2020

Clinical correlations of patterns of placental pathology in preterm pre-eclampsia

1 reference

12 December 2020

Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly pr

1 reference

12 December 2020

Should anticardiolipin tests be performed in otherwise healthy pregnant women?

1 reference

12 December 2020

10.1007/S11926-007-0035-9

Identifiers

DOI

1 reference

16 August 2017

1 reference